Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.
A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations.
FTDs for US listed companies are reported to the SEC and published twice a month.
Therefore there is a certain delay between the reporting and the publishing of the data.
Failures to deliver for Bio-Techne (TECH) - 3 month history
Number of shares, 3 month chart
Biweekly Failures to deliver volume for Bio-Techne (TECH) - since 2014
Volume in USD (price x number of shares), data since 2014
Bio-Techne (TECH) Failure to deliver volume, Year over Year
Volume (Price x Shares)
FTD volume in the last 3 months for similar companies or competitors
The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.
CompaniesMarketCap.com is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.
For inquiries or if you want to report a problem write to helnospamlo@8market(nospam)cap.com